GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Health Anxiety Linked to Increased Use of Both Traditional and Alternative Healthcare Services in Norway Study

by GOAI
Share To

A recent study conducted as part of the Tromsø7 Study in Norway has examined the relationship between health anxiety and the use of medical services. Researchers Norbye, Ringberg, and Kristoffersen investigated how individuals with health anxiety utilize both traditional healthcare services and complementary or alternative medicine. The study highlights a significant association between heightened health anxiety and increased medical visits across these categories.

The research, carried out within the Norwegian population, focused on understanding how psychological factors such as health anxiety influence healthcare-seeking behavior. Findings indicate that individuals experiencing higher levels of health anxiety are more likely to seek frequent consultations with general practitioners and specialists. Additionally, they are more inclined to explore complementary or alternative treatments alongside conventional medical care. The study provides insight into patterns of healthcare utilization linked to mental health concerns, offering a deeper understanding of how psychological conditions may impact healthcare systems.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top